D-1276-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1276-2019 was initiated by American Health Packaging on Apr 8, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero. The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 2,203 cartons (cartons of 30 individual unit doses).

Recall details

Product Type
Drugs
Report Date
May 8, 2019
Initiation Date
Apr 8, 2019
Termination Date
Nov 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,203 cartons (cartons of 30 individual unit doses)

Product description

GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21

Reason for recall

Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.

Distribution pattern

Nationwide in the USA

Code information

Lot # 181288, EXP 5/31/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1276-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1276-2019. Report a data issue: hello@regdatalab.com.